Rewind Therapeutics
PrivateLast Round
Series A
Extension
Jan 25, 2023
Total Funding Raised
$21.6M
Company Overview
Rewind Therapeutics is a biotechnology company that develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from diseases such as multiple sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rewind Therapeutics Comparables
Compare Rewind Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convelo Therapeutics | 87% | |
| Progentos Therapeutics | 86% | |
| Find Therapeutics | 86% | |
Rewind Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 25, 2023 | ||||
| Grant | Aug 2, 2019 | ||||
| Series A | Jan 4, 2018 |
Rewind Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series A Extension |
| Centre for Drug Design and Discovery | Series A Extension, Series A |
| VLAIO | Grant |
| PMV | Series A Extension, Series A |
| Boehringer Ingelheim Venture Fund | Series A Extension, Series A |
| Sunstone Life Science Ventures | Series A Extension |
| M Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2019
$3.2M grant received from VLAIO.
Rewind Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rewind Therapeutics's valuation, stock price, and market status.